Clinical Trials Logo

Chemo Fog clinical trials

View clinical trials related to Chemo Fog.

Filter by:
  • None
  • Page 1

NCT ID: NCT05014399 Recruiting - Clinical trials for Cognitive Impairment

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Chemo Brain
Start date: September 20, 2021
Phase:
Study type: Observational

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.

NCT ID: NCT04092647 Recruiting - Chemo Fog Clinical Trials

Ashwagandha for Cognitive Dysfunction

Start date: January 1, 2023
Phase: Phase 2
Study type: Interventional

This is a 1:1 randomized double blinded placebo controlled trial. • To determine if ashwagandha can improve cognitive dysfunction when compared with placebo in patients undergoing chemotherapy for cancer.

NCT ID: NCT02312934 Completed - Breast Cancer Clinical Trials

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Start date: August 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the use of a nicotine patch as a treatment for problems with attention, learning and memory in breast cancer patients who are 1-5 years post chemotherapy.